{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:51:27Z","timestamp":1788457887521,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11655-025-3845-6","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:48:52Z","timestamp":1761533332000},"page":"223-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sanren Decoction Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Protecting Mitochondrial Function"],"prefix":"10.1007","volume":"32","author":[{"given":"Yi-xiao","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-hua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"3845_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2022;7:851\u2013861.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3845_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","volume":"165","author":"S Man","year":"2023","unstructured":"Man S, Deng Y, Ma Y, Fu J, Bao H, Yu C, et al. Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China. Gastroenterology 2023;165:1025\u20131040.","journal-title":"Gastroenterology"},{"key":"3845_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2337\/dc20-1778","volume":"44","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Monti T, Perseghin G. High prevalence of advanced liver fibrosis assessed by transient elastography among U.S. adults with type 2 diabetes. Diabetes Care 2021;44:519\u2013525.","journal-title":"Diabetes Care"},{"key":"3845_CR4","doi-asserted-by":"publisher","first-page":"101154","DOI":"10.1016\/j.molmet.2020.101154","volume":"45","author":"CE Shannon","year":"2021","unstructured":"Shannon CE, Ragavan M, Palavicini JP, Fourcaudot M, Bakewell TM, Valdez IA, et al. Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease. Mol Metab 2021;45:101154.","journal-title":"Mol Metab"},{"key":"3845_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","volume":"84","author":"SJ Keam","year":"2024","unstructured":"Keam SJ. Resmetirom: first approval. Drugs 2024;84:729\u2013735.","journal-title":"Drugs"},{"key":"3845_CR6","first-page":"2320","volume":"42","author":"Y Yin","year":"2022","unstructured":"Yin Y, Tang H, Liu W, Fang Y. Effects of effective fractions of Sanren Decoction on nonalcoholic fatty liver induced by high-fat diet in mice. Chin J Hospital Pharmacy (Chin) 2022;42:2320\u20132324.","journal-title":"Chin J Hospital Pharmacy (Chin)"},{"key":"3845_CR7","first-page":"1092","volume":"43","author":"YX Yin","year":"2023","unstructured":"Yin YX, Tang H, Fang Y, Liu W, Wang Jun, Hu YY, et al. Hepatic transcriptome delineates the therapeutic effects of Sanren Tang on high-fat diet-induced non-alcoholic fatty liver disease. J Tradit Chin Med 2023;43:1092\u20131002.","journal-title":"J Tradit Chin Med"},{"key":"3845_CR8","first-page":"99","volume":"33","author":"C Cao","year":"2023","unstructured":"Cao C, Li L, Zi M, Fu J, Ren J, Li L, et al. Methods for determining animal sample sizes in medical experimental studies. Chin J Comp Med (Chin) 2023;33:99\u2013105.","journal-title":"Chin J Comp Med (Chin)"},{"key":"3845_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jtcme.2023.07.008","volume":"14","author":"H Tang","year":"2024","unstructured":"Tang H, Wang J, Fang Y, Yin Y, Liu W, Hu Y, et al. Hepatic transcriptome discloses the potential targets of Xuefu Zhuyu Decoction ameliorating non-alcoholic fatty liver disease induced by high-fat diet. J Tradit Complement Med 2024;14:135\u2013147.","journal-title":"J Tradit Complement Med"},{"key":"3845_CR10","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fphar.2018.01399","volume":"9","author":"JH Peng","year":"2018","unstructured":"Peng JH, Leng J, Tian HJ, Yang T, Fang Y, Feng Q, et al. Geniposide and chlorogenic acid combination ameliorates non-alcoholic steatohepatitis involving the protection on the gut barrier function in mouse induced by high-fat diet. Frontiers Pharmacol 2018;9:1399.","journal-title":"Frontiers Pharmacol"},{"key":"3845_CR11","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313\u20131321.","journal-title":"Hepatology"},{"key":"3845_CR12","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.clinbiochem.2007.05.009","volume":"40","author":"M Vogeser","year":"2007","unstructured":"Vogeser M, K\u00f6nig D, Frey I, Predel HG, Parhofer KG, Berg A. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons. Clin Biochem 2007;40:964\u2013968.","journal-title":"Clin Biochem"},{"key":"3845_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2016.06.005","volume":"24","author":"KF Petersen","year":"2016","unstructured":"Petersen KF, Befroy DE, Dufour S, Rothman DL, Shulman GI. Assessment of hepatic mitochondrial oxidation and pyruvate cycling in NAFLD by 13C magnetic resonance spectroscopy. Cell Metab 2016;24:167\u2013171.","journal-title":"Cell Metab"},{"key":"3845_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"NE Sunny","year":"2011","unstructured":"Sunny NE, Parks EJ, Browning JD, Burgess SC. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 2011;14:804\u2013810.","journal-title":"Cell Metab"},{"key":"3845_CR15","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/hep.32324","volume":"76","author":"MP Moore","year":"2022","unstructured":"Moore MP, Cunningham RP, Meers GM, Johnson SA, Wheeler AA, Ganga RR, et al. Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD. Hepatology 2022;76:1452\u20131465.","journal-title":"Hepatology"},{"key":"3845_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab 2015;21:739\u2013746.","journal-title":"Cell Metab"},{"key":"3845_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s13181-011-0162-6","volume":"7","author":"J Grundlingh","year":"2011","unstructured":"Grundlingh J, Dargan PI, El-Zanfaly M, Wood DM. 2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death. J Med Toxicol 2011;7:205\u2013212.","journal-title":"J Med Toxicol"},{"key":"3845_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","volume":"78","author":"B Fromenty","year":"2023","unstructured":"Fromenty B, Roden M. Mitochondrial alterations in fatty liver diseases. J Hepatol 2023;78:415\u2013429.","journal-title":"J Hepatol"},{"key":"3845_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.molcel.2015.12.002","volume":"61","author":"I Martfnez-Reyes","year":"2016","unstructured":"Martfnez-Reyes I, Diebold LP, Kong H, Schieber M, Huang H, Hensley CT, et al. TCA cycle and mitochondrial membrane potential are necessary for diverse biological functions. Molecular Cell 2016;61:199\u2013209.","journal-title":"Molecular Cell"},{"key":"3845_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, et al. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B 2022;12:558\u2013580.","journal-title":"Acta Pharm Sin B"},{"key":"3845_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12013-013-9750-1","volume":"68","author":"M Akram","year":"2014","unstructured":"Akram M. Citric acid cycle and role of its intermediates in metabolism. Cell Biochem Biophys 2014;68:475\u2013478.","journal-title":"Cell Biochem Biophys"},{"key":"3845_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/cells10040762","volume":"10","author":"EV Prochownik","year":"2021","unstructured":"Prochownik EV, Wang H. The metabolic fates of pyruvate in normal and neoplastic cells. Cells 2021;10:762.","journal-title":"Cells"},{"key":"3845_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","volume":"78","author":"B Fromenty","year":"2023","unstructured":"Fromenty B, Roden M. Mitochondrial alterations in fatty liver diseases. J Hepatol 2023;78:415\u2013429.","journal-title":"J Hepatol"},{"key":"3845_CR24","doi-asserted-by":"publisher","first-page":"e77088","DOI":"10.1371\/journal.pone.0077088","volume":"8","author":"AR Cardoso","year":"2013","unstructured":"Cardoso AR, Kakimoto PA, Kowaltowski AJ. Diet-sensitive sources of reactive oxygen species in liver mitochondria: role of very long chain acyl-CoA dehydrogenases. PLoS One 2013;8:e77088.","journal-title":"PLoS One"},{"key":"3845_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.redox.2015.02.003","volume":"4","author":"PA Kakimoto","year":"2015","unstructured":"Kakimoto PA, Tamaki FK, Cardoso AR, Marana SR, Kowaltowski AJ. H2O2 release from the very long chain acyl-CoA dehydrogenase. Redox Biol 2015;4:375\u2013380.","journal-title":"Redox Biol"},{"key":"3845_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","volume":"52","author":"AP Rolo","year":"2012","unstructured":"Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 2012;52:59\u201369.","journal-title":"Free Radic Biol Med"},{"key":"3845_CR27","doi-asserted-by":"publisher","first-page":"102529","DOI":"10.1016\/j.clinre.2025.102529","volume":"49","author":"A Borgne-Sanchez","year":"2025","unstructured":"Borgne-Sanchez A, Fromenty B. Mitochondrial dysfunction in drug-induced hepatic steatosis: recent findings and current concept. Clin Res Hepatol Gastroenterol 2025;49:102529.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3845_CR28","unstructured":"Steinberg GR, Valvano CM, De Nardo W, Watt MJ. Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms. J Hepatol 2025;S0168-8278(25)00142-4."},{"key":"3845_CR29","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2337\/dc21-1758","volume":"45","author":"S Gancheva","year":"2022","unstructured":"Gancheva S, Kahl S, Pesta D, Mastrototaro L, Dewidar B, Strassburger K, et al. Impaired hepatic mitochondrial capacity in nonalcoholic steatohepatitis associated with type 2 diabetes. Diabetes Care 2022;45:928\u2013937.","journal-title":"Diabetes Care"},{"key":"3845_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","volume":"28","author":"NE Sunny","year":"2017","unstructured":"Sunny NE, Bril F, Cusi K. Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies. Trends Endocrinol Metab 2017;28:250\u2013260.","journal-title":"Trends Endocrinol Metab"},{"key":"3845_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41580-021-00415-0","volume":"23","author":"I Vercellino","year":"2022","unstructured":"Vercellino I, Sazanov LA. The assembly, regulation and function of the mitochondrial respiratory chain. Nat Rev Mol Cell Biol 2022;23:141\u2013161.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3845_CR32","doi-asserted-by":"publisher","first-page":"166935","DOI":"10.1016\/j.bbadis.2023.166935","volume":"1870","author":"H Chen","year":"2024","unstructured":"Chen H, Jin C, Xie L, Wu J. Succinate as a signaling molecule in the mediation of liver diseases. Biochim Biophys Acta Mol Basis Dis 2024;1870:166935.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3845_CR33","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1007\/s00018-019-03200-7","volume":"76","author":"B Moosavi","year":"2019","unstructured":"Moosavi B, Berry EA, Zhu XL, Yang WC, Yang GF. The assembly of succinate dehydrogenase: a key enzyme in bioenergetics. Cell Mol Life Sci 2019;76:4023\u20134042.","journal-title":"Cell Mol Life Sci"},{"key":"3845_CR34","doi-asserted-by":"publisher","first-page":"e2106947118","DOI":"10.1073\/pnas.2106947118","volume":"118","author":"RK Aggarwal","year":"2021","unstructured":"Aggarwal RK, Luchtel RA, Machha V, Tischer A, Zou Y, Pradhan K, et al. Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer. Proc Natl Acad Sci U S A 2021;118:e2106947118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3845_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mito.2017.12.002","volume":"42","author":"M Jodeiri Farshbaf","year":"2018","unstructured":"Jodeiri Farshbaf M, Kiani-Esfahani A. Succinate dehydrogenase: prospect for neurodegenerative diseases. Mitochondrion 2018;42:77\u201383.","journal-title":"Mitochondrion"},{"key":"3845_CR36","doi-asserted-by":"publisher","first-page":"27255","DOI":"10.1074\/jbc.M112.374629","volume":"287","author":"CL Quinlan","year":"2012","unstructured":"Quinlan CL, Orr AL, Perevoshchikova IV, Treberg JR, Ackrell BA, Brand MD. Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J Biol Chem 2012;287:27255\u201327264.","journal-title":"J Biol Chem"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-3845-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-025-3845-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-3845-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:53:50Z","timestamp":1772261630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-025-3845-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3845"],"URL":"https:\/\/doi.org\/10.1007\/s11655-025-3845-6","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"6 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest. Peng Jing-hua serves on the Youth Editorial Board of\n                      Chinese Journal of Integrative Medicine.\n                      The paper was handled by the other editor and has undergone rigorous peer review process. Peng Jing-hua was not involved in the journal\u2019s review of or decisions related to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}